21.85 (1.35%) Sun Pharmaceutical Industries has informed that it enclosed certificate as per para 4 of Annexure II to the SEBI Circular No. SEBI/HO/DDHS/DDHS/CIR/P/2019/115 dated October 22, 2019.
The above information is a part of company’s filings submitted to BSE.